Literature DB >> 29049135

Early Identification of the Patient with Endotheliopathy of Trauma by Arrival Serum Albumin.

Erika Gonzalez Rodriguez1, Jessica C Cardenas1, Ernesto Lopez1, Bryan A Cotton1, Jeffrey S Tomasek1, Sisse R Ostrowski2, Lisa A Baer1, Jakob Stensballe2,3, John B Holcomb1, Pär I Johansson1,2, Charles E Wade1.   

Abstract

OBJECTIVE: Traumatic endotheliopathy (EoT) is associated with glycocalyx breakdown and capillary leak resulting in the extravasation of proteins. We hypothesized that lower serum albumin levels are associated with EoT, poor outcomes, and can be used for early EoT screening in trauma patients.
METHODS: We enrolled severely injured trauma patients with serum albumin levels available on admission. Syndecan-1 and soluble thrombomodulin were quantified from plasma by ELISA. Demographic and clinical data were obtained. We evaluated the association of serum albumin and EoT+ (syndecan-1 level ≥40 ng/mL), followed by dichotomization by serum albumin level, and subgroup comparisons.
RESULTS: Of the 258 patients enrolled 92 (36.0%) were EoT+ (syndecan-1 ≥ 40 ng/mL). Median albumin levels in the EoT+ group were 3.4 g/dL, and 3.8 g/dL in EoT- patients, P < 0.05. In a multifactorial analysis, lower albumin levels were inversely associated with the likelihood of EoT+. With receiver characteristic curve analysis, we determined a cutoff albumin level < 3.6 g/dL for EoT+ prediction (area under the curve 0.70; 95% CI: 0.63, 0.77). After dichotomizing by albumin <3.6 or ≥3.6 g/dL, 51.5% of patients had low albumin. Low albumin patients were more likely to have EoT+, as well as higher soluble thrombomodulin (both P < 0.05). Furthermore, they required more frequently blood transfusions, had fewer hospital-free days and higher mortality rate than those with normal albumin.
CONCLUSIONS: EoT is a syndrome associated with leakage of albumin from the intravascular compartment, which re-emphasizes that arrival albumin may be a novel and timely approach to the identification of patients needing endothelial rescue therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29049135     DOI: 10.1097/SHK.0000000000001036

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury.

Authors:  Lucy Z Kornblith; Anamaria J Robles; Amanda S Conroy; Carolyn M Hendrickson; Carolyn S Calfee; Alexander T Fields; Rachael A Callcut; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2018-11       Impact factor: 3.313

2.  Positive Fluid Balance and Association with Post-Traumatic Acute Kidney Injury.

Authors:  Gabrielle E Hatton; Reginald E Du; Shuyan Wei; John A Harvin; Kevin W Finkel; Charles E Wade; Lillian S Kao
Journal:  J Am Coll Surg       Date:  2019-11-14       Impact factor: 6.113

Review 3.  Trauma-induced coagulopathy: The past, present, and future.

Authors:  Lucy Z Kornblith; Hunter B Moore; Mitchell J Cohen
Journal:  J Thromb Haemost       Date:  2019-05-13       Impact factor: 5.824

4.  Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma.

Authors:  Joseph D Krocker; Kyung Hyun Lee; Hanne H Henriksen; Yao-Wei Willa Wang; Erwin M Schoof; Sigurdur T Karvelsson; Óttar Rolfsson; Pär I Johansson; Claudia Pedroza; Charles E Wade
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

5.  Traumatic brain injury is associated with increased syndecan-1 shedding in severely injured patients.

Authors:  Erika Gonzalez Rodriguez; Jessica C Cardenas; Charles S Cox; Ryan S Kitagawa; Jakob Stensballe; John B Holcomb; Pär I Johansson; Charles E Wade
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-11-21       Impact factor: 2.953

6.  Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study.

Authors:  Hironori Matsumoto; Jun Takeba; Kensuke Umakoshi; Satoshi Kikuchi; Muneaki Ohshita; Suguru Annen; Naoki Moriyama; Yuki Nakabayashi; Norio Sato; Mayuki Aibiki
Journal:  Thromb J       Date:  2018-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.